CG Oncology (CGON) Financials: Revenue & Earnings

CGON price $63.96 +1.02 +1.62%

Ticker
CGON
Price
$63.96
Change
+1.02 +1.62%
Market cap ?
$5.67B
P/E ?
-23.16
Forward P/E ?
24.06
Dividend yield ?
0.00%
Beta ?
0.24
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
60
Value
43
Quality
45
Growth
93

Stocklytics score rationale: value 43, quality 45, growth 93.

Financials

20212022202320242025
1035800019100020400011390004040000

CG Oncology, Inc., a late-stage clinical biopharmaceutical company, develops and commercializes cretostimogene grenadenorepvec for patients with bladder cancer in the United States. The company’s product candidate is cretostimogene, an investigational oncolytic immunotherapy, which is in phase 2 clinical trials of cretostimogene in patients with high-risk NMIBC after BCG failure; a phase 3 clinical trials to…

Fair value

CGON fair value $34.36. Price $63.96. Price is 86% above fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 1.30M. Growth 7.33%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 88.64M. Net debt -25.47M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Model uncertainty high for this stock

Compare CGON

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-13—-0.83—547.68K
2026-08-06-0.90-0.661.16M360.81K
2026-05-08-0.71-0.581.08M453.03K
2026-02-27-0.51-0.612.31M450.54K
2025-11-14-0.57-0.561.67M59.36K
2025-08-08-0.54-0.49—81.62K
2025-05-13-0.45-0.3952.00K118.17K
2025-03-28-0.48-0.41456.00K123.95K
2024-11-14—-0.42——
2024-08-08-0.28-0.42111.00K—
2024-05-09-0.36-0.35529.00K—
2024-03-26—-0.67——

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-15Kalofonos IsabelBuy92.00K$61.865.69M
2026-10-15POST LEONARD ESell1.00K$0.60600
2026-10-15POST LEONARD EBuy1.00K$0.60600
2026-10-15POST LEONARD ESell500$61.6530.82K
2026-10-15POST LEONARD ESell500$62.4831.24K
2026-10-13Kalofonos IsabelOther0——
2026-09-15POST LEONARD ESell1.00K$0.60600
2026-09-15POST LEONARD EBuy1.00K$0.60600
2026-09-15POST LEONARD ESell1.00K$72.9872.98K
2026-08-14POST LEONARD ESell1.00K$0.60600
2026-08-14POST LEONARD EBuy1.00K$0.60600
2026-08-14POST LEONARD ESell1.00K$74.5474.54K
2026-07-15POST LEONARD ESell1.00K$0.60600
2026-07-15POST LEONARD EBuy1.00K$0.60600
2026-07-15POST LEONARD ESell1.00K$71.1771.17K
2026-07-10Mulay JamesBuy24.16K$26.63643.51K
2026-07-10Mulay JamesSell24.16K$75.161.82M
2026-07-10Mulay JamesSell24.16K$26.63643.51K
2026-06-25Liu Brian Guan-ChyunBuy371.08K$66.8724.81M
2026-06-24POST LEONARD ESell5.00K$0.603.00K
2026-06-24POST LEONARD EBuy5.00K$0.603.00K
2026-06-24POST LEONARD ESell5.00K$70.00350.00K
2026-06-22POST LEONARD ESell5.00K$0.603.00K
2026-06-22POST LEONARD EBuy5.00K$0.603.00K
2026-06-22POST LEONARD ESell5.00K$65.00325.00K
2026-06-15Mulay JamesSell1.31K$12.5916.49K
2026-06-15Mulay JamesBuy1.31K$12.5916.49K
2026-06-15Mulay JamesBuy654$3.722.43K
2026-06-15Mulay JamesSell654$3.722.43K
2026-06-15Mulay JamesSell1.31K$60.1278.76K
2026-06-04Liu Brian Guan-ChyunBuy9.35K$56.09524.67K
2026-06-04Tong Victor Edward JrBuy9.35K$56.09524.67K
2026-06-04Mulay JamesBuy9.35K$56.09524.67K
2026-06-04POST LEONARD ESell1.00K$0.60600
2026-06-04Rossi ChristinaBuy9.35K$56.09524.67K
2026-06-04POST LEONARD EBuy9.35K$56.09524.67K
2026-06-04POST LEONARD EBuy1.00K$0.60600
2026-06-04POST LEONARD ESell1.00K$54.5054.50K
2026-06-04Graf Susan EBuy9.35K$56.09524.67K
2026-04-17Mulay JamesBuy15.60K$36.63571.43K
2026-04-17Mulay JamesSell15.60K$73.011.14M
2026-04-17Mulay JamesSell15.60K$36.63571.43K
2026-04-15Bellete AmbawBuy107.51K$67.687.28M
2026-04-15Kasturi VijayBuy79.22K$67.685.36M
2026-04-15Patterson Joshua F.Buy45.27K$67.683.06M
2026-04-15DETORE JAMES M.Buy90.57K$67.686.13M
2026-04-15Kuan ArthurBuy271.60K$67.6818.38M
2026-03-16Mulay JamesSell1.31K$12.5916.49K
2026-03-16Mulay JamesBuy1.31K$12.5916.49K
2026-03-16Mulay JamesBuy654$3.722.43K
2026-03-16Mulay JamesSell654$3.722.43K
2026-03-16Mulay JamesSell1.31K$63.5083.19K
2026-03-12Kuan ArthurBuy64.61K$1.72111.13K
2026-03-12Kuan ArthurSell1.85K$60.15111.10K
2026-03-12Kuan ArthurSell64.61K$1.72111.13K
2026-03-04Kuan ArthurBuy102.87K$1.72176.94K
2026-03-04Kuan ArthurSell2.87K$61.61176.88K
2026-03-04Kuan ArthurSell102.87K$1.72176.94K
2026-01-09Mulay JamesBuy10.49K$12.59132.08K
2026-01-09Mulay JamesSell10.49K$12.59132.08K
2026-01-09Mulay JamesSell654$3.722.43K
2026-01-09Mulay JamesBuy654$3.722.43K
2026-01-09Mulay JamesSell654$44.1628.88K
2026-01-09Mulay JamesSell10.49K$52.99555.92K
2025-11-24Rossi ChristinaBuy20.89K$43.56909.92K
2025-11-24Rossi ChristinaOther0——
2025-11-17DETORE JAMES M.Other0——
2025-11-17POST LEONARD ESell1.00K$0.60600
2025-11-17POST LEONARD EBuy1.00K$0.60600
2025-11-17POST LEONARD ESell1.00K$41.4341.43K
2025-10-13POST LEONARD ESell1.00K$0.60600
2025-10-13POST LEONARD EBuy1.00K$0.60600
2025-10-13POST LEONARD ESell1.00K$43.2543.25K
2025-10-09Mulay JamesBuy5.90K$3.7221.96K
2025-10-09Mulay JamesSell5.90K$3.7221.96K
2025-10-09Mulay JamesSell5.90K$43.99259.67K
2025-09-30POST LEONARD ESell5.00K$0.603.00K
2025-09-30POST LEONARD EBuy5.00K$0.603.00K
2025-09-30POST LEONARD ESell5.00K$40.09200.45K
2025-09-29Mulay JamesBuy12.76K$1.8223.21K
2025-09-29Mulay JamesSell12.76K$1.8223.21K
2025-09-29Mulay JamesSell12.76K$39.19499.87K
2025-09-19Mulay JamesSell3.57K$1.826.50K
2025-09-19Mulay JamesBuy3.57K$1.826.50K
2025-09-19Mulay JamesSell3.57K$38.99139.35K
2025-09-18Mulay JamesBuy19.11K$1.8234.78K
2025-09-18Mulay JamesSell19.11K$1.8234.78K
2025-09-18Mulay JamesSell19.11K$39.01745.56K
2025-09-15POST LEONARD ESell1.00K$0.60600
2025-09-15POST LEONARD EBuy1.00K$0.60600
2025-09-15POST LEONARD ESell1.00K$35.1035.10K
2025-09-11Liu Brian Guan-ChyunBuy1.52M$33.0050.00M
2025-09-05Mulay JamesBuy27.02K$0.6016.21K
2025-09-05Mulay JamesSell12.34K$30.47376.06K
2025-09-05Mulay JamesSell4.09K$31.42128.66K
2025-09-05Mulay JamesSell7.46K$32.64243.66K
2025-09-05Mulay JamesSell27.02K$0.6016.21K
2025-09-05Mulay JamesSell3.11K$33.22103.41K
2025-09-03Song Hong FangSell69.69K$27.601.92M
2025-09-03Song Hong FangSell30.11K$28.24850.17K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 246, holders 0 vs prior quarter. Ownership 111.76%.

HolderSharesChangeChange %Value
RTW INVESTMENTS, LP8.51M1.53M+21.90%604.96M
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.6.62M-103.49K-1.54%470.13M
DECHENG CAPITAL LLC6.37M00.00%452.71M
BLACKROCK, INC.6.26M1.19M+23.54%444.51M
WELLINGTON MANAGEMENT GROUP LLP5.32M-46.48K-0.87%378.32M
FMR LLC4.16M396.65K+10.54%295.67M
PRICE T ROWE ASSOCIATES INC /MD/3.81M152.03K+4.16%270.35M
TCG CROSSOVER MANAGEMENT, LLC3.67M00.00%260.77M
VANGUARD PORTFOLIO MANAGEMENT LLC3.47M370.10K+11.96%246.20M
STATE STREET CORP3.44M790.54K+29.86%244.24M
VANGUARD CAPITAL MANAGEMENT LLC3.32M283.17K+9.33%235.66M
FORESITE CAPITAL MANAGEMENT VI LLC2.37M148.10K+6.67%168.36M
GEODE CAPITAL MANAGEMENT, LLC2.15M556.41K+34.84%153.02M
SEVEN FLEET CAPITAL MANAGEMENT LP1.89M1.81M+2389.82%134.02M
CAPTION MANAGEMENT, LLC1.78M1.40M+370.09%126.41M
ECOR1 CAPITAL, LLC1.49M392.30K+35.60%106.17M
DV TRADING LLC1.44M00.00%102.27M
AVIDITY PARTNERS MANAGEMENT LP1.40M110.00K+8.53%99.40M
FRANKLIN TEMPLETON INC1.31M-194.12K-12.88%93.28M
ALLIANCEBERNSTEIN L.P.1.37M84.06K+6.52%93.00M
CAPTION MANAGEMENT, LLC1.20M816.72K+215.79%84.92M
MORGAN STANLEY1.18M656.90K+126.27%83.63M
ACORN CAPITAL ADVISORS, LLC1.13M999+0.09%80.39M
FORESITE CAPITAL MANAGEMENT V, LLC1.08M75.00K+7.47%76.67M
LOGOS GLOBAL MANAGEMENT LP1.00M425.00K+73.91%71.05M

Earnings and financials

CG Oncology Inc. (CGON) trades at $63.96, with a market cap of $5.67B and a trailing P/E of -23.16. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

20212022202320242025
1035800019100020400011390004040000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

CG Oncology (CGON) Financials: Revenue & Earnings

CGON$63.96+1.02 +1.62%

$5.67B

Market Cap

-23.16

P/E

24.06

Forward P/E

60

Score

Price History